Association of Insulin Resistance, Plasma Glucose Level, and Serum Insulin Level With Hypertension in a Population With Different Stages of Impaired Glucose Metabolism.
Aged
Atomic Bomb Survivors
Biomarkers
/ blood
Blood Glucose
/ metabolism
Blood Pressure
Cross-Sectional Studies
Diabetes Mellitus
/ blood
Female
Glucose Intolerance
/ blood
Humans
Hypertension
/ diagnosis
Insulin
/ blood
Insulin Resistance
Japan
/ epidemiology
Male
Middle Aged
Prevalence
Prognosis
Time Factors
diabetes mellitus
hyperglycemia
hyperinsulinemia
hypertension
insulin resistance
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
07 04 2020
07 04 2020
Historique:
entrez:
24
3
2020
pubmed:
24
3
2020
medline:
9
3
2021
Statut:
ppublish
Résumé
Background The interrelationships among the different stages of impaired glucose metabolism, insulin resistance, and hypertension are not fully understood. Methods and Results We investigated the impact of insulin resistance, plasma glucose, and serum immunoreactive insulin levels on hypertension in 19 166 participants with different stages of impaired glucose metabolism (7114 normal fasting glucose/normal glucose tolerance, 3543 isolated impaired fasting glucose [IFG], 2089 isolated impaired glucose tolerance, 2922 IFG plus impaired glucose tolerance, and 3498 diabetes mellitus]) determined by 75-g oral glucose tolerance tests. Participants were recruited from examinees who finished a general health checkup for atomic bomb survivors between 1982 and 2017. The profiles of plasma glucose and immunoreactive insulin during oral glucose tolerance tests were assessed using the total area under the curve. Insulin resistance was assessed using the homeostasis model assessment of insulin resistance. The rate of hypertension increased from 36.3% in participants with normal fasting glucose/normal glucose tolerance to 50.1%, 50.8%, 58.3%, and 63.8% in participants with isolated IFG, isolated impaired glucose tolerance, IFG plus impaired glucose tolerance, and diabetes mellitus, respectively. Homeostasis model assessment of insulin resistance was associated with hypertension regardless of the presence and the degree of impaired glucose metabolism. Furthermore, fasting plasma glucose and serum immunoreactive insulin levels and areas under the curve for plasma glucose and immunoreactive insulin during oral glucose tolerance tests were associated with hypertension in normal fasting glucose/normal glucose tolerance and isolated IFG, but such a relationship was diminished in other types of prediabetes and diabetes mellitus. Conclusions The prevalence of hypertension increases with worsening stages of impaired glucose metabolism; however, hyperglycemia and hyperinsulinemia are significant contributors to the presence of hypertension only in the early stages of impaired insulin metabolism.
Identifiants
pubmed: 32200720
doi: 10.1161/JAHA.119.015546
pmc: PMC7428612
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Insulin
0
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e015546Références
Am Heart J. 1991 Apr;121(4 Pt 2):1268-73
pubmed: 2008855
Nature. 2001 Dec 13;414(6865):799-806
pubmed: 11742412
J Intern Med. 2003 Nov;254(5):464-71
pubmed: 14535968
Cell. 1998 Mar 6;92(5):593-6
pubmed: 9506512
J Cell Physiol. 2019 Feb;234(2):1300-1312
pubmed: 30146696
Life Sci. 2014 May 28;104(1-2):32-7
pubmed: 24732303
Diabetes Care. 1999 May;22(5):818-22
pubmed: 10332688
Diabetes Care. 2010 Jul;33(7):e93
pubmed: 20587713
High Blood Press Cardiovasc Prev. 2016 Sep;23(3):175-9
pubmed: 26942609
N Engl J Med. 1987 Aug 6;317(6):350-7
pubmed: 3299096
Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
pubmed: 20042772
Diabetes Care. 1999 Feb;22(2):228-32
pubmed: 10333938
Cell Metab. 2011 Nov 2;14(5):575-85
pubmed: 22055501
Hypertension. 1997 Jan;29(1 Pt 2):280-5
pubmed: 9039115
Hypertension. 2001 Apr;37(4):1053-9
pubmed: 11304502
J Clin Endocrinol Metab. 2003 Jun;88(6):2399-403
pubmed: 12788834
Diabetes Care. 1994 Nov;17(11):1247-51
pubmed: 7821162
Diabetes Care. 2019 Dec;42(12):2322-2329
pubmed: 31591089
Hypertension. 2004 Jun;43(6):1324-31
pubmed: 15123571
J Am Heart Assoc. 2020 Apr 7;9(7):e015546
pubmed: 32200720
Hypertens Res. 2018 Jun;41(6):389-393
pubmed: 29556093
Circ Res. 2019 Mar 15;124(6):930-937
pubmed: 30646822
Cell Metab. 2010 May 5;11(5):379-89
pubmed: 20444418
Diabetologia. 2014 Dec;57(12):2465-74
pubmed: 25226881
J Clin Invest. 2003 May;111(9):1373-80
pubmed: 12727929
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Hypertension. 2018 Mar;71(3):422-428
pubmed: 29335249
Hypertens Res. 2015 May;38(5):349-54
pubmed: 25693857
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
Diabetes Care. 2006 Aug;29(8):1909-14
pubmed: 16873801
Diabetes Care. 2007 Jan;30(1):89-94
pubmed: 17192339